Potential new multiple sclerosis treatment
November 19th, 2010 - 5:16 pm ICT by ANIWashington, Nov 19 (ANI): Professor Linda Watkins of the University of Colorado at Boulder says that successfully treating and reversing the effects of multiple sclerosis (MS), may be possible one day using a drug originally developed to treat chronic pain.
Watkins and her colleagues in CU-Boulder’s department of psychology and neuroscience discovered that a single injection of a compound called ATL313 — an anti-inflammatory drug being developed to treat chronic pain — stopped the progression of MS-caused paralysis in rats for weeks at a time.
Lisa Loram, a senior research associate spearheaded the project in Watkins’ laboratory.
MS is an inflammatory disease where the body’s immune system attacks a protective sheath called myelin that encompasses nerves in the spinal cord and brain. As the disease progresses, the myelin develops lesions, or scars, that cause permanent neurological problems.
Watkins, Loram and their colleagues hope to use spinal cord and brain-imaging technology to extend their studies to determine if lesions are being healed in rats that received an ATL313 injection.
“If we have a drug that is able to heal these lesions, this treatment could be a major breakthrough in how we treat the symptoms of MS in the future,” she said.
The findings will be presented at the Society for Neuroscience’s annual meeting held in San Diego this week. (ANI)
- New treatment could help minimize nerve damage in spinal cord injuries - May 04, 2011
- Viagra reverses nerve disease: Study - May 22, 2011
- 'Axonal damage is reversible' in multiple sclerosis - Mar 28, 2011
- Single shot relieves pain in spinal injuries - Dec 02, 2011
- Potential therapeutic target for multiple sclerosis identified - Jan 12, 2011
- New treatment to heal spinal injuries - Nov 17, 2011
- Cheap BP drug could help treat multiple sclerosis - Aug 18, 2009
- Multiple sclerosis 'could be reversed by activating stem cells in brain' - Dec 06, 2010
- Boffins find protein that lets brain repair damage from multiple sclerosis - Jun 08, 2010
- Gene therapy boosts cell repair in brain disorders - Feb 12, 2012
- Statins 'slow multiple sclerosis progression' - Apr 15, 2010
- Ginkgo Biloba extracts could treat pain, inflammation - Apr 28, 2011
- FDA approves first oral drug that reduces multiple sclerosis relapses - Sep 22, 2010
- Clues on inflammation in central nervous system uncovered - Oct 22, 2010
- Chemical hormone that can help find right connection after spinal cord injury identified - Aug 03, 2009
Tags: brain imaging, colorado at boulder, cu boulder, department of psychology, imaging technology, inflammatory disease, inflammatory drug, lesions, linda watkins, loram, multiple sclerosis treatment, myelin, neurological problems, protective sheath, sclerosis ms, society for neuroscience, symptoms of ms, time lisa, university of colorado, university of colorado at boulder